BACKGROUND: Only cobalamin carried by transcobalamin (holo-transcobalamin) is available for cellular uptake and hence is physiologically relevant. However, no reliable or accurate methods for quantifying holo-transcobalamin are available. We report a novel holo-transcobalamin assay based on solid-phase capture of transcobalamin. METHODS: A monoclonal antibody specific for human transcobalamin with an affinity constant >10(10) L/mol was immobilized on magnetic microspheres to capture and concentrate transcobalamin. The cobalamin bound to transcobalamin was then released and assayed by a competitive binding radioassay. The quantification of holo-transcobalamin was accomplished using calibrators composed of recombinant, human holo-transcobalamin. RESULTS: The assay was specific for holo-transcobalamin and had a detection limit of 5 pmol/L. Within-run and total imprecision (CV) was 5% and 8-9%, respectively. The working range (CV <20%) was 5-370 pmol/L. Dilutions of serum were linear in the assay range. The recovery of recombinant, human holo-transcobalamin added to serum was 93-108%. A 95% reference interval of 24-157 pmol/L was established for holo-transcobalamin in 105 healthy volunteers 20-80 years of age. For 72 of these sera, holo-haptocorrin and total cobalamin were also determined. Whereas holo-haptocorrin correlated well (r(2) = 0.87) with total cobalamin, holo-transcobalamin correlated poorly (r(2) = 0.23) with total cobalamin or holo-haptocorrin. CONCLUSIONS: The solid-phase capture assay provides a simple, reliable method for quantitative determination of holo-transcobalamin in serum.
BACKGROUND: Only cobalamin carried by transcobalamin (holo-transcobalamin) is available for cellular uptake and hence is physiologically relevant. However, no reliable or accurate methods for quantifying holo-transcobalamin are available. We report a novel holo-transcobalamin assay based on solid-phase capture of transcobalamin. METHODS: A monoclonal antibody specific for human transcobalamin with an affinity constant >10(10) L/mol was immobilized on magnetic microspheres to capture and concentrate transcobalamin. The cobalamin bound to transcobalamin was then released and assayed by a competitive binding radioassay. The quantification of holo-transcobalamin was accomplished using calibrators composed of recombinant, human holo-transcobalamin. RESULTS: The assay was specific for holo-transcobalamin and had a detection limit of 5 pmol/L. Within-run and total imprecision (CV) was 5% and 8-9%, respectively. The working range (CV <20%) was 5-370 pmol/L. Dilutions of serum were linear in the assay range. The recovery of recombinant, human holo-transcobalamin added to serum was 93-108%. A 95% reference interval of 24-157 pmol/L was established for holo-transcobalamin in 105 healthy volunteers 20-80 years of age. For 72 of these sera, holo-haptocorrin and total cobalamin were also determined. Whereas holo-haptocorrin correlated well (r(2) = 0.87) with total cobalamin, holo-transcobalamin correlated poorly (r(2) = 0.23) with total cobalamin or holo-haptocorrin. CONCLUSIONS: The solid-phase capture assay provides a simple, reliable method for quantitative determination of holo-transcobalamin in serum.
Authors: C Lewerin; H Nilsson-Ehle; S Jacobsson; H Johansson; V Sundh; M K Karlsson; Ö Ljunggren; M Lorentzon; J A Kanis; U H Lerner; S R Cummings; C Ohlsson; D Mellström Journal: Osteoporos Int Date: 2013-10-16 Impact factor: 4.507
Authors: Luciana Hannibal; Scott D Bunge; Rudi van Eldik; Donald W Jacobsen; Christoph Kratky; Karl Gruber; Nicola E Brasch Journal: Inorg Chem Date: 2007-04-04 Impact factor: 5.165
Authors: Marjorie G Garrod; Ralph Green; Lindsay H Allen; Dan M Mungas; William J Jagust; Mary N Haan; Joshua W Miller Journal: Clin Chem Date: 2008-05-01 Impact factor: 8.327
Authors: Irene Pusceddu; Markus Herrmann; Susanne H Kirsch; Christian Werner; Ulrich Hübner; Marion Bodis; Ulrich Laufs; Thomas Widmann; Stefan Wagenpfeil; Jürgen Geisel; Wolfgang Herrmann Journal: Eur J Nutr Date: 2016-07-05 Impact factor: 5.614
Authors: Iris Iglesia; Theodora Mouratidou; Marcela González-Gross; Inge Huybrechts; Christina Breidenassel; Javier Santabárbara; Ligia-Esperanza Díaz; Lena Hällström; Stefaan De Henauw; Frédéric Gottrand; Anthony Kafatos; Kurt Widhalm; Yannis Manios; Denes Molnar; Peter Stehle; Luis A Moreno Journal: Eur J Nutr Date: 2016-05-25 Impact factor: 5.614